NCBI PubMed Central
open access
Pathology-guided multimodal transformer predicts postoperative survival benefit from adjuvant chemotherapy in glioma: from DNA damage repair to immune characterization.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse#856553
- Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)#889272
- Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)#1384323
- Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study#1150876
- Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence#1466268
Record · ID 1513351
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive